Molina Healthcare (NYSE:MOH) Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of Molina Healthcare (NYSE:MOH) from a hold rating to a sell rating in a report published on Saturday morning.

MOH has been the subject of several other research reports. Sanford C. Bernstein lowered their price target on Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating for the company in a report on Friday, September 5th. The Goldman Sachs Group reduced their price target on Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a research report on Friday. Cantor Fitzgerald cut their target price on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating on the stock in a research report on Friday. UBS Group cut their target price on Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, JPMorgan Chase & Co. cut their target price on Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 29th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $203.64.

Molina Healthcare Trading Down 0.9%

Shares of MOH stock opened at $161.88 on Friday. Molina Healthcare has a fifty-two week low of $151.95 and a fifty-two week high of $359.97. The stock has a market cap of $8.77 billion, a P/E ratio of 10.02 and a beta of 0.55. The business has a fifty day simple moving average of $184.05 and a 200-day simple moving average of $236.74. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). The firm had revenue of $11.48 billion during the quarter, compared to analysts’ expectations of $10.99 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.01 EPS. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. On average, analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Ronna Romney sold 700 shares of the company’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO James Woys purchased 10,000 shares of the firm’s stock in a transaction dated Monday, August 4th. The stock was acquired at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the purchase, the chief operating officer owned 74,331 shares of the company’s stock, valued at approximately $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. 1.26% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Versant Capital Management Inc boosted its stake in Molina Healthcare by 202.8% during the third quarter. Versant Capital Management Inc now owns 2,126 shares of the company’s stock valued at $407,000 after buying an additional 1,424 shares in the last quarter. Kera Capital Partners Inc. boosted its stake in Molina Healthcare by 432.5% during the third quarter. Kera Capital Partners Inc. now owns 4,111 shares of the company’s stock valued at $787,000 after buying an additional 3,339 shares in the last quarter. Concurrent Investment Advisors LLC lifted its holdings in shares of Molina Healthcare by 31.1% during the third quarter. Concurrent Investment Advisors LLC now owns 1,238 shares of the company’s stock valued at $237,000 after purchasing an additional 294 shares during the last quarter. Bogart Wealth LLC acquired a new position in shares of Molina Healthcare in the 3rd quarter valued at $39,000. Finally, Quent Capital LLC acquired a new position in shares of Molina Healthcare in the 3rd quarter valued at $129,000. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.